Approval · Notice of Compliance 11672 · 2010
INTELENCE: Notice of Compliance 11672
Issued August 19, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11672
- Date
- August 19, 2010
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the Dosage and Administration section and other revisions to the Product Monograph
- Therapeutic class
- Human immunodeficiency virus (HIV) non-nucleoside reverse transcriptase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTELENCE | Not yet assigned | — |
Medicinal ingredients
- ETRAVIRINE 100 MG per TAB